CIK 0001824293
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824369909
- Phone
- +1 619-400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- 4 Grant or award Chief Medical Officer acquired 172,189 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 172,189 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Director disposed of 28,517 shares (other)
- 4 Grant or award Director acquired 38,023 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 6,250 shares at an average $4.03 ($25,175)
- 4 Open-market buy Director bought 17,500 shares at an average $4.10 ($71,795)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 4 · 73 filings